BackJaguar Health Overview

Jaguar Health Inventory

Latest inventory for JAGX: $7.8M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$7.82M
↓ 25.92% YoYΔ $-2.74M vs prior year quarter

Peer average / median

Loading

Jaguar Health Inventory History

Loading

Jaguar Health vs. peers: Inventory Comparison

Loading

Jaguar Health Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Jaguar Health (JAGX) FAQ

As of the most recent data (March 2026), JAGX shows a inventory of $7.8M. That compares with $11M in the prior-year period — down 25.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JAGX's inventory is now $7.8M (was $11M) — a 25.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jaguar Health is outperforming or lagging.

Tracking JAGX's inventory over time shows whether Jaguar Health is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $11M in the prior-year period — down 25.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Jaguar Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $7.8M) with ownership activity and broader fundamentals.

Jaguar Health's inventory is $7.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.